\small
\begin{tabular}{llrcl}
  \toprule
  Parameter                          & Stratum                   &      Value &      Range       & Ref \\
  \midrule
  Population size                    & overall                   &    100,000 &                  & \cite{Wang2021}\tn{a} \\
                                     & fraction in city A        &        .50 &    [.20,~.80]    & \tn{a} \\
  Fraction higher risk               & city A                    &        .10 & [.01,~.50]\tn{b} & \cite{Wang2021}\tn{a} \\
                                     & city B                    &        .10 &                  & \cite{Wang2021}\tn{a} \\[1ex]
  Contact rate                       & close non-sexual, all     &          1 &                  & \cite{Milwid2022}\tn{a} \\
                                     & sexual, lower risk        &        .01 &                  & \cite{Wang2021}\tn{a} \\
                                     & sexual, higher risk, city A & .189\tn{c} & [.10,~.25]\tn{b} & \cite{Wang2021,Endo2022}\tn{a} \\
                                     & sexual, higher risk, city B & .189\tn{c} &                  & \cite{Wang2021,Endo2022}\tn{a} \\[1ex]
  Assortativity\tn{d}                & cities, all contacts      &        .90 &    [.70,~1.0]    & \cite{Armstrong2020}\tn{a} \\
                                     & risk, close non-sexual    &          0 &                  & \tn{a} \\
                                     & risk, sexual              &        .50 &                  & \tn{a} \\
  Per-contact \SAR                   & close non-sexual          &  .01\tn{e} &                  & \cite{Beer2019,Thornhill2022} \\
                                     & sexual                    &  .90\tn{c} &                  & \cite{Endo2022}\tn{a} \\[1ex]
  Initial infections                 & overall                   &         10 &                  & \tn{a} \\
                                     & fraction in city A        &        .50 &    [0.0,~1.0]    & \tn{a} \\[1ex]
  Duration of period                 & latent/incubation         &          8 &                  & \cite{Charniga2022,Thornhill2022,Miura2022,Guzzetta2022} \\
                                     & infectious/symptoms       &         21 &                  & \cite{Adler2022,Thornhill2022} \\
  Fraction of infectious period isolated &                       &        .50 &                  & \cite{Thornhill2022,deBaetselier2022}\tn{a} \\[1ex]
  Vaccines available                 &                           &      5000 &                  & \tn{a} \\
  Vaccine effectiveness\tn{f}        &                           &        .85 &                  & \cite{Fine1988,NACI2022vax,CDC2022vax} \\
  Vaccine prioritization sensitivity & higher risk               &        .90 &                  & \cite{TPH2022vax}\tn{a} \\
  Vaccine allocation                 & city A                    &        .50 & [0.0,~1.0]\tn{g} & --- \\
  \bottomrule
\end{tabular}
\floatfoot
All durations in days; all rates in per-day.
\SAR: secondary attack rate.
\tnt[a]{Assumed / representative.}
\tnt[b]{Calculated to fit $R_0 \in [1,2]$.}
\tnt[c]{Calculated to fit $R_0 = 1.5$,
  reflecting pre-vaccination estimate of \MPXV $R_0$ in Ontario \cite{PHO2022ont}
  via \cite{EpiNow2}.}
\tnt[d]{Fraction of all contacts formed exclusively within-group;
  0 implies random mixing; 1 implies no mixing.}
\tnt[e]{Calibrated to fit approximately 95\% incidence via sexual vs close, non-sexual contacts.}
\tnt[f]{Leaky-type: partial protection among vaccinated.}
\tnt[g]{Optimized parameter.}